Business Description
CervoMed is a Boston-based biotech company focused on treating brain diseases that worsen with age. Its lead drug, neflamapimod, is a pill that enters the brain and blocks a protein linked to nerve cell damage, with the goal of preserving brain function and slowing disease progression. The company is currently testing neflamapimod in patients with several serious conditions, including dementia with Lewy bodies, a progressive speech disorder, and ALS.
